Chengdu Easton Biopharmaceuticals Co., Ltd.

Shanghai Stock Exchange 688513.SS

Chengdu Easton Biopharmaceuticals Co., Ltd. Dividends Paid for the year ending December 31, 2023: USD -10.01 M

Chengdu Easton Biopharmaceuticals Co., Ltd. Dividends Paid is USD -10.01 M for the year ending December 31, 2023, a 26.25% change year over year. Dividends paid is cash paid to shareholders as a distribution of profits.

Chengdu Easton Biopharmaceuticals Co., Ltd. Dividends Paid for the year ending December 31, 2022 was USD -13.57 M, a -139.40% change year over year.
Chengdu Easton Biopharmaceuticals Co., Ltd. Dividends Paid for the year ending December 31, 2021 was USD -5.67 M, a -5,215.36% change year over year.
Chengdu Easton Biopharmaceuticals Co., Ltd. Dividends Paid for the year ending December 31, 2020 was USD -106.67 K, a 96.70% change year over year.
Chengdu Easton Biopharmaceuticals Co., Ltd. Dividends Paid for the year ending December 31, 2019 was USD -3.23 M, a 0.00% change year over year.

Key data

Date	Dividends Paid	Capital Expenditure	Other Financing Activities	Net Cash Used Provided By Financing Activities

Shanghai Stock Exchange: 688513.SS

Chengdu Easton Biopharmaceuticals Co., Ltd.

CEO	Mr. Mingxu Yuan
IPO Date	Sept. 2, 2020
Location	China
Headquarters	No.8, Xiyuan Avenue
Employees	1,400
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry , and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.

Key trends

Past 5 years